Trans-catheter aortic valve replacement (tavr) as bridge therapy restoring eligibility for liver transplantation in cirrhotic patients

Archive ouverte

Levy, Clementine | Lassailly, Guillaume | El Amrani, Mehdi | Vincent, Flavien | Delhaye, Cedric | Meurice, Thibault | Boleslawski, Emmanuel | Millet, Guillaume | Ningarhari, Massih | Truant, Stéphanie | Louvet, Alexandre | Mathurin, Philippe | Lebuffe, Gilles | Pruvot, Francois-Rene | Dharancy, Sebastien

Edité par CCSD ; Elsevier -

International audience. Severe aortic stenosis is a widespread valve disease, constituting a contraindication to organ transplantation due to cardiovascular morbidity and projected mortality. Mortality after conventional surgical aortic valve replacement in cirrhotic patients depends upon the Child-Pugh class. In the past few years, transcatheter aortic valve replacement has progressively become the treatment of choice for high-risk patients with severe aortic stenosis. Here, we report the cases of 3 cirrhotic patients who became eligible for liver transplantation after successful transcatheter aortic valve replacement as bridge therapy.

• Description
• Sujet/Public
• Outil
• Outil d'anticipation
• Mémoire et thèse
• Gestion